Abstract Details

Title National Trends In Utilization And Outcomes Of Acute Ischemic Stroke And Intracerebral Hemorrhage Patients Undergoing Gastrostomy Tube Placement

Topic Neuro Trauma and Critical Care

Presentation(s) P6 - Poster Session 6 (5:30 PM-6:30 PM)

Poster/Presentation
Number 1-003

Background NA

Objective Persistent dysphagia requiring gastrostomy tube placement continues to be a major issue for stroke patients. We performed analysis to evaluate trends in utilization of gastrostomy tube placement and associated rates of death among acute ischemic stroke (IS) and intracerebral hemorrhage (ICH) patients over a 10-year period

Design/Methods We obtained data for patients admitted to hospitals in United States from 2009 to 2018 with a primary diagnosis of IS or ICH using a large national database. We determined rate and pattern of utilization and associated in-hospital outcomes of gastrostomy tube placement among IS and ICH patients.

Results Total of 50551 (7.05%) and 136922 (2.45%) patients underwent gastrostomy tube placement among 716777and 5567538 patients admitted with ICH and IS, respectively. There was 3.2-fold decrease in patients who gastrostomy tube placement among patients with IS (2.3% in 2009 vs 0.7% in 2018; P<0.001), and by a 1.5-fold decrease for those with ICH (7.8% in 2009 vs 5.3% in 2018; P<0.001). Rates of in-hospital mortality among patients undergoing gastrostomy tube placement remained unchanged throughout 10 years for patients with IS (5.2% in 2009 vs 4.9% in 2018; p = 0.54) but decreased by 1.5-fold for those with ICH (7.58% in 2009 vs 2.7% in 2010; p = 0.01). Length of hospitalization remained significantly higher in patients undergoing gastrostomy tube placement compared with those who did not for both patients with IS (16.2 ±15.7versus 3.6±4.3, p<.0001) and those with ICH (24.4±22.1 versus 6.0±7.5, p<.0001). Cost of hospitalization remained significantly higher in patients undergoing gastrostomy tube placement compared with those who did not for both patients with IS.

Conclusions Between 2009 and 2018, there was significant reduction in the proportion of IS and ICH patients who underwent gastrostomy tube placement. Length and cost of hospitalization remained significantly higher among patients who underwent gastrostomy tube placement

Authors/Disclosures
Mohammad Rauf A. Chaudhry, MD PRESENTER	Dr. Chaudhry has nothing to disclose.
	No disclosure on file
Danish Kherani, MD	Dr. Kherani has nothing to disclose.
	No disclosure on file
Mohammad Ghatali, MD (Texas Tech Health Science Center)	Dr. Ghatali has nothing to disclose.
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Faheem G. Sheriff, MD (Texas Tech Neurology)	Dr. Sheriff has nothing to disclose.
Anantha Vellipuram, MD (Piedmont)	Dr. Vellipuram has nothing to disclose.
Alberto Maud, MD (Paul L. Foster School of Medicine Texas Tech UHSC El Paso, Texas)	Dr. Maud has nothing to disclose.
Paisith Piriyawat, MD (Texas Tech University)	Dr. Piriyawat has nothing to disclose.
Gustavo J. Rodriguez, MD (Gustavo J. Rodriguez)	Dr. Rodriguez has nothing to disclose.
Isabel Victoria Narvaez- Correa, MD	Dr. Narvaez- Correa has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.

��ɫ��

��ɫ��